Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Kaumil Gajrawala

Jefferies · covers Consumer Defensive

Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q3 (9 quarters).

Questions
62on tracked calls
Challenge rate
19%12 of 62 questions
Companies
11questioned at least once
Reporting periods
9with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 62 of 62 questions from 11 companies

PEPPepsiCo9 questions · 8 reporting periods · 2 of 9 challenging
PEP company page →

Calendar 2026 Q3

Then on beverages, the word urgency you have used many times. What does that mean?

ChallengingCompetitive DynamicsMarginTranscript · FY2026 Q3 →
Show response

Laguarta defined urgency as cutting non-growth costs, funding brands and raising execution standards, while reviewing partnerships and execution choices.

what exactly is the plan? Which direction are you, what is the correct direction of travel?

PricingCompetitive DynamicsTranscript · FY2026 Q3 →
Show response

Laguarta said pricing will blend revenue management and productivity to absorb new inflation while staying affordable; no explicit direction on list price.

Calendar 2026 Q2

I'm just struggling a little bit to understand what optimizing return on investment means.

ChallengingPricingDemandMarginTranscript · FY2026 Q2 →
Show response

Laguarta clarified it means maximizing volume from trade investments customer-by-customer and holiday-by-holiday: simpler on everyday-low-price accounts, more complex on high-low where tweaks are focused.

Calendar 2026 Q1

you had mentioned the very substantial increase in the number of occasions. Can you maybe dig into that a little bit more

DemandProduct LaunchCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

Ramon described two consumer types: lapsed buyers returning through optimized value in multipacks, and new category entrants attracted by innovations like Naked and Gatorade with no artificial ingredients.

Calendar 2025 Q4

is this within the salty-snack aisle, or with the incremental shelf space, maybe in other parts of the store

DemandCompetitive DynamicsTranscript · FY2025 Q4 →
Show response

Ramon confirmed gains in both main shelf and perimeter, driven by increased unit throughput from affordability investments requiring more store capacity for in-store and online fulfillment.

Calendar 2025 Q3

To what degree are you open to the idea of franchising some of these operations on the beverage side

Capital AllocationMarginTranscript · FY2025 Q3 →
Show response

Ramon said open to all ideas and all perspectives, but framed answer around three strategic considerations: future demand patterns (digital, delivery), technology enablement, and full PepsiCo P&L optimization. Did not commit to specific refranchising plans.

Calendar 2025 Q2

that was quite the tease on the big launch in protein. There is anything you could add

Product LaunchPricingTranscript · FY2025 Q2 →
Show response

Ramon confirmed protein launch coming in a few months but declined specifics for competitive reasons. Jamie noted affordability is being addressed with much more precision by channel, pack size, and time of month.

Calendar 2025 Q1

what do you think about the launch of GLP-1 oral medications coming to market next year

Competitive DynamicsDemandTranscript · FY2025 Q1 →
Show response

Ramon noted GLP-1 consumers driving more protein, fiber, and hydration consumption; PEP well-positioned in fiber and hydration but innovating in protein. Current adoption around 7-8%.

Calendar 2024 Q4

I just wonder if these restructurings are maybe a prelude to something bigger down the road or maybe what's your appetite for that

Capital AllocationM&ATranscript · FY2024 Q4 →
Show response

Ramon explained the restructuring rationale as capturing international growth with focused organizations and US cost efficiencies, not a prelude to a split.

PGThe Procter & Gamble Company9 questions · 8 reporting periods · 0 of 9 challenging
PG company page →

Calendar 2026 Q2

Are those real run rates or do you feel like you can pick them up?

Revenue GrowthCompetitive DynamicsInnovation & R&DTranscript · FY2026 Q4 →
Show response

Schulten confirmed the base assumption is stable category growth and explained the sequence varies by category, using baby care value correction versus innovation-led category lift as the contrast.

Calendar 2026 Q1

it's not just commodity costs, but all the other sort of things that come with it as part of that $1 billion

Cost PressureSupply ChainTranscript · FY2026 Q3 →
Show response

Andre broke down the $1B into four components: petro-based feedstock costs, less efficient sourcing lanes with higher transportation, reformulation upcharges, and finished product logistics from diesel.

we're starting to see some public companies, especially in their filings, talk about potential tariff refunds

Trade TariffsRegulation PolicyTranscript · FY2026 Q3 →
Show response

Andre confirmed about $150M after tax in potential IEEPA tariff refunds available but said recoverability depends on the U.S. administration laying out the process.

Calendar 2025 Q4

to the extent that you're able to calculate what actual usage is in the households, has that sort of trended off

Show response

Andre said volume slow/flat through H1; improving value proposition without price changes key to reigniting usage and penetration; slow recovery expected.

Calendar 2025 Q3

Was there anything onetime in there as it relates to sort of a near-term benefit from flipping

Trade TariffsGeographic ExpansionTranscript · FY2026 Q1 →
Show response

Andre said no one-time effects; tariff relief came from broad exemptions on non-U.S. grown materials; benefits expected to accelerate.

Calendar 2025 Q2

is there a bit of a philosophical pivot or shift in any way that would be related to the timing of this

Capital AllocationCompetitive DynamicsTranscript · FY2025 Q4 →
Show response

Jon denied any philosophical pivot; attributed superiority gaps partly to cheap high-quality Chinese supply flowing into global markets.

Calendar 2025 Q1

is it slowing your, you know, the pace of innovation rollouts or expectations from contribution of those innovations

Show response

Andre said innovation pace unchanged; focus is on simplicity and restaging, working with retailers on shelf simplification.

Calendar 2024 Q4

if we can maybe dig in a little bit more on consumer health or healthcare, it's -- the comp was a bit easier

Show response

Jon attributed softness to a mild cough-cold season, but said share is still being built within cough-cold.

Calendar 2024 Q3

are you seeing trading down? How you're thinking about that in the context of promotional activity

Show response

Andre described a stable, below-pre-COVID promo environment, no trading down, and flat private-label share; no material destocking.

CLXClorox8 questions · 7 reporting periods · 2 of 8 challenging
CLX company page →

Calendar 2026 Q2

Why not maybe a higher figure for investment as you just to assure that you don't end up back in the situation

ChallengingCapex InvestmentCompetitive DynamicsTranscript · FY2026 Q4 →
Show response

Linda argued FY2026 bumpiness stemmed from ERP/operational disruption, not underinvestment, and that spend is targeted and adequate.

Calendar 2025 Q4

Can you maybe just talk about what you should be able to do now, what you see, maybe some cadence of benefits that flow through

Capex InvestmentMarginTranscript · FY2026 Q2 →
Show response

Luc: Remainder of year focused on stabilizing (incremental costs go away by Q4). Then optimization phase: redesign processes, reskill workforce. Benefits in supply chain (manufacturing, logistics) both P&L and balance sheet plus admin automation. Accelerating global business services adoption. All feeds pipeline of 25-50bps annual EBIT margin expansion. Gross margin expansion generally in line with EBIT expansion.

Calendar 2025 Q3

When you're making adjustments for it, how do you feel about your market shares? Are they trending in a direction that you prefer the opposite?

Competitive DynamicsDemandTranscript · FY2026 Q1 →
Show response

Luc unpacked: -3% ex-ERP = -1% underlying + 1pt timing benefit - 3pts out-of-stock headwind. Linda said share declined more than expected due to ERP ramp-up, particularly August. Not satisfied but fundamentals strong (household penetration stable, consumer value metric high). Laser-focused on recovery.

Calendar 2025 Q2

we're hearing from yourselves and other household goods companies on a weak consumer, but we're also hearing the opposite from a lot of other industries

ChallengingMacroeconomicDemandTranscript · FY2025 Q4 →
Show response

Linda said consumer fundamentals are fine but uncertainty is driving wallet trade-offs. Consumers buying experiences and convenience (wipes 40% Scentiva growth) while conserving on some essentials. One wallet managing multiple priorities. Not structurally unhealthy, under stress from uncertainty.

Calendar 2025 Q1

when I look between divisions, and I see that how much more it seemed to impact households than some of the other divisions

Show response

Linda explained retail sales (consumption) was similar across portfolio, Household sales gap driven by: retailer inventory adjustments in heavy goods, Kingsford timing/weather, Litter lapping prior-year promo. Not structurally different from other categories.

Calendar 2024 Q4

Can you maybe just give some more details on this 1% to 2% from turning ERP on, just -- I just don't -- I guess, I don't understand how it works from a practical perspective.

Capex InvestmentInnovation & R&DTranscript · FY2025 Q2 →
Show response

Luc explained U.S. ERP go-live July with phased manufacturing transition over six months. Shipping ahead of consumption to retailers + building own safety stock in Q4. Reverses in front half FY2026.

Calendar 2024 Q3

as you're thinking about how to get the consumer to come back, promos is a piece of it, but I suppose marketing is also quite a large piece of it

Competitive DynamicsProduct LaunchTranscript · FY2025 Q1 →
Show response

Linda described multi-pronged approach: new advertising, digital claims, subscription re-engagement, plus innovation plans for back half. Strategy working but more to come.

I was asking about ERP and what you've learned so far from Canada and what the timeline looks like for the U.S.

Capex InvestmentInnovation & R&DTranscript · FY2025 Q1 →
Show response

Linda said Canada ERP went smoothly; retailers barely noticed. U.S. implementation much more complex, to begin end of FY2025 with phased approach.

KOThe Coca-Cola Company7 questions · 7 reporting periods · 2 of 7 challenging
KO company page →

Calendar 2026 Q2

Is it fair to say you should be towards the high end of that at a base level

Revenue GrowthGuidance ReliabilityTranscript · FY2026 Q2 →
Show response

Murphy explicitly committed to the higher end of the 4% to 6% algorithm as the ambition on a sustained basis.

Calendar 2026 Q1

for the first time this emergence of what seems like an entirely new channel with the Dutch Bros and brews of the world

ChallengingCompetitive DynamicsDemandTranscript · FY2026 Q1 →
Show response

Henrique defended McDonald's relationship as intact, highlighted Sprite Berry Blast and Lunar Splash performing well in craft beverage space, deflected specifics on Red Bull.

Calendar 2025 Q4

So making adjustments there, it looks like quite a slowdown

ChallengingGuidance ReliabilityMarginTranscript · FY2025 Q4 →
Show response

John cited three factors: top line reflects momentum plus recovery needed in key markets, bias to invest ahead of the curve in brands and capabilities, and structural cycling plus below-the-line items from Coca-Cola Consolidated divestiture.

Calendar 2025 Q3

Can we dig a little more maybe on the consumer and CPG, particularly in the U.S. and Europe

DemandMacroeconomicTranscript · FY2025 Q3 →
Show response

James distinguished beverage industry as structural growth category (4-5% annually for decades). Plans AI and agentic tech-driven productivity plus 2026 restructuring to fund continued growth.

Calendar 2025 Q2

Can you maybe just talk about the operating leverage across the P&L given how much has changed so far

Show response

John noted G10 hedges somewhat offsetting actual dollar weakness. EM currencies less hedged. Will provide 2026 FX outlook on October call.

Calendar 2025 Q1

since John and James your arrival, it's been about dollar based growth and worked very hard to be able to grow earnings in dollar terms

FxCapital AllocationTranscript · FY2025 Q1 →
Show response

John cautioned against reading dollar weakness from DXY since it only covers 6 currencies, heavily euro-weighted. Will flow through dollar weakness if it materializes broadly.

Calendar 2024 Q4

can you maybe just talk about how you think about cash or capital allocation when you're on the other side of it

Capital AllocationTranscript · FY2024 Q4 →
Show response

John acknowledged increased flexibility in 2026 but was nonspecific on M&A or buyback plans, calling it premature to detail 2026 capital allocation.

STZConstellation Brands6 questions · 6 reporting periods · 3 of 6 challenging
STZ company page →

Calendar 2026 Q3

Does that mean the right level is that same new higher level that you had earlier in the year?

MarginCompetitive DynamicsTranscript · FY2027 Q2 →
Show response

Fink said current marketing levels are healthy and do not imply higher spend; Hankinson is comfortable with full-year spend, but no run-rate figure was given.

Calendar 2025 Q3

what can you do about it if they don't have as much money, they're not as willing to go out

DemandCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Bill detailed Oro repricing to target high-end light beer, Premier repositioned at lower price point with early positive results. Price pack architecture ensures brands are available at accessible price points.

Calendar 2025 Q2

could this be sort of the equivalent of a COVID moment that even if things start to open up a bit that maybe the behavior doesn't go back to where it was

ChallengingDemandMacroeconomicTranscript · FY2026 Q1 →
Show response

Bill distinguished between consumer interest (unchanged) and occasions (reduced), restaurants and social gatherings declining, but not a preference shift. Expects reversion when macro normalizes.

Calendar 2025 Q1

it feels like maybe some of it is structural and that could be a law of large numbers. Is there maybe a revision in expectations for Hispanic population growth

ChallengingDemandCompetitive DynamicsTranscript · FY2025 Q4 →
Show response

Bill denied structural issues, citing awareness gaps vs competition, shelf position runway, Modelo expansion into non-Hispanic community, and increased marketing returns.

Calendar 2024 Q4

How do you maybe think about the right amount of CapEx that you're deploying into new capacity given that we've got this slowdown

ChallengingCapital AllocationCapex InvestmentTranscript · FY2025 Q3 →
Show response

Bill emphasized modular approach to capacity, noted $1.9B remaining buyback authorization. Garth highlighted approaching cash flow inflection with bias toward returning capital to shareholders.

Calendar 2024 Q3

now that you're there, what the appetite is for more aggressively repurchasing shares

Capital AllocationTranscript · FY2025 Q2 →
Show response

Garth detailed $450M YTD repurchases and $2.2B remaining authorization, confirming continued opportunistic buyback approach.

CLColgate-Palmolive5 questions · 5 reporting periods · 0 of 5 challenging
CL company page →

Calendar 2026 Q2

Is it something that snaps back later and it could be a tailwind into the back half?

Show response

Noel did not assume an inventory snap-back in guidance, focusing on driving consumption, and framed the Fresh launch as science-led and vet-driven.

Calendar 2025 Q4

for how long can that continue? Maybe there's a little promotional activity

DemandMacroeconomicFxTranscript · FY2025 Q4 →
Show response

Wallace attributed slowdown to consumer uncertainty causing pantry destocking and lower category penetration. Expects categories have bottomed but slow recovery. Sutula said FX used as flexibility in business model.

Calendar 2025 Q2

There's been some kind of debate about the category, the pet food category in general on -- if it had been fading

Competitive DynamicsDemandProduct LaunchTranscript · FY2025 Q2 →
Show response

Wallace attributed to strategy execution not macro: therapeutic growing faster than wellness, broad-based growth across wet/dry/treats/dog/cat. Private label production ceased in July. Category flat.

Calendar 2025 Q1

do you feel like you have a sense of the sort of why behind the slowdown in February

MacroeconomicDemandPricingTranscript · FY2025 Q1 →
Show response

Wallace attributed slowdown to macro uncertainty causing consumer caution and pantry destocking. Sutula noted oil down but palm/tallow up, modest net inflation expected.

Calendar 2024 Q4

If you could just talk a bit about the what's going on with volumes, particularly in Europe, is this something cyclical

DemandCompetitive DynamicsInnovation & R&DTranscript · FY2024 Q4 →
Show response

Wallace attributed volume drag to private label (200bps) but highlighted 3% underlying growth, strong shares, prescription diet recovery. Sutula described RGM 2.0 as analytics-enabled pricing and promotion optimization.

Show 5 more companies
KDPKeurig Dr Pepper5 questions · 5 reporting periods · 0 of 5 challenging
KDP company page →

Calendar 2026 Q1

Is that total company guidance? Or is it, I guess, legacy KDP?

Guidance ReliabilityCapital AllocationTranscript · FY2026 Q1 →
Show response

Anthony confirmed HSG Q2 EPS guidance is total company including JDE Peet's. Free cash flow of $2.5B expected in 2026 including 9 months of JDE Peet's. Leverage targets at separation: BevCo 3.5-4x, Global Coffee Co 3.75-4.25x. Noncore asset divestitures being assessed but declined to provide specifics.

Calendar 2025 Q3

Why were they the best partners? I believe they have a Board member coming on

Capital AllocationM&ATranscript · FY2025 Q3 →
Show response

Jane cited strategic conviction in both successor companies from Apollo/KKR. Financial expertise and transaction experience adds value. Brian Driscoll to be nominated to board.

Calendar 2025 Q2

Do you have as much infrastructure as is necessary to be able to take on a brand of that size?

Competitive DynamicsGeographic ExpansionTranscript · FY2025 Q2 →
Show response

Tim explained DSD expansion strategy including Arizona acquisition, digital tools investment, and new California/Nevada/Midwest Dr Pepper distribution. Acknowledged short-term disruption from transition.

Calendar 2025 Q1

Blackberry is already 1% market share and was only lost in February. How big of a contributor will it be for the year?

Product LaunchRevenue GrowthTranscript · FY2025 Q1 →
Show response

Tim highlighted Dr Pepper Blackberry launched across formats (bottles, cans, fountain, frozen) and achieved nearly 1 share point in just 8 weeks. Full funnel marketing support underway.

Calendar 2024 Q4

the new, at least big, hot thing seems to be around modern soda. There's been some transactions in the place

Competitive DynamicsProduct LaunchTranscript · FY2024 Q4 →
Show response

Tim acknowledged the opportunity without committing to a specific strategy. Said 60% of portfolio is positive hydration. Would consider organic or partnerships for health-conscious white spaces.

TAPMolson Coors Beverage Company5 questions · 5 reporting periods · 3 of 5 challenging
TAP company page →

Calendar 2026 Q2

is now the right time to be cutting costs or buying back shares as opposed to maybe really stepping it up

ChallengingCapital AllocationCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Rahul stressed investing first in core, Value and Above Premium brands plus Beyond Beer M&A, with disciplined cost savings and buybacks alongside. Tracey said strong cash generation lets the company fund brands, M&A and buybacks simultaneously, with priorities varying quarter to quarter.

Calendar 2026 Q1

Are there any sort of big risks or big sort of things that you're thinking about, you really want to sort of go for in this first 12 months?

Competitive DynamicsCapital AllocationTranscript · FY2026 Q1 →
Show response

Rahul pointed to aggressive portfolio transformation (Beyond Beer from ~10% of revenue with intent to grow meaningfully), reorientation to local execution, reallocation of marketing spend to occasions like live sports, and championing beer category health. Tracey said strong balance sheet provides optionality, long-term view on share value tied to sustainable growth strategy.

Calendar 2025 Q3

is this just the first step and there's bigger restructuring to come?

ChallengingCost PressureCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Rahul said more to come on total plan in coming months. The Americas restructuring was the short-term action to set up for 2026. Cost and efficiency is a super important element but committed to sharing full plan later.

Calendar 2025 Q1

we're maybe getting the earliest signs of maybe increased promotional activity or increased focus on value in some way

PricingCompetitive DynamicsTranscript · FY2025 Q1 →
Show response

Gavin acknowledged continued value-seeking behavior by channel and pack but said promotional activity is not unusual, with typical summer intensity expected.

Calendar 2024 Q4

Why is sort of a small stake, the right amount with whatever P&L that contributes to your business versus the P&L that goes to the distributors

ChallengingM&AGeographic ExpansionTranscript · FY2024 Q4 →
Show response

Gavin framed Fever-Tree as fitting the string-of-pearls M&A approach, slightly bigger but strategic. Canada's success attributed to broad-based brand strength, premiumization with Miller Lite and Madri, and fastest-growing RTD position.

CELHCelsius Holdings, Inc.4 questions · 4 reporting periods · 0 of 4 challenging
CELH company page →

Calendar 2026 Q2

which leads to a weaker net all-in number than we would have expected, I think than you guys would have expected

Revenue GrowthProduct LaunchCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

CEO argued limited-time offers become less material as Alani's base SKU count and repeat purchase build out; general on how the comps get managed quarter to quarter.

Calendar 2025 Q3

Curious how you're thinking about the price point, not just of Celsius, but also Alani and Rockstar.

PricingCost PressureTranscript · FY2025 Q3 →
Show response

John said pricing and promotional strategy are under evaluation and a revenue-management team is being built, but declined to announce any pricing action.

Calendar 2025 Q1

we're seeing energy drinks as a category accelerate at a time where almost everything else in CPG

DemandCompetitive DynamicsTranscript · FY2025 Q1 →
Show response

Fieldly credited category resilience plus a wave of health-and-wellness innovation driving consumer trial; a direct read on category health.

Calendar 2024 Q4

Can you maybe talk about the positioning of the two brands and how you plan to solve for maybe any any

Competitive DynamicsM&ATranscript · FY2024 Q4 →
Show response

Management framed Alani Nu's ~92% female consumer base as incremental with low cannibalization; a substantive, direct answer.

MNSTMonster Beverage3 questions · 3 reporting periods · 0 of 3 challenging
MNST company page →

Calendar 2026 Q2

I'd like to dig into the commentary around the pricing. It sounds like it's some global decisions.

Show response

Rob Gehring described consistent U.S. pricing to drive revenue ahead of volume and profit ahead of revenue; Guy Carling said EMEA took aggregate low-single-digit pricing on an opportunistic basis.

Calendar 2025 Q3

A question on the contribution of affordable energy around the world and its sort of impact on margins

MarginGeographic ExpansionTranscript · FY2025 Q3 →
Show response

CEO explained international pricing constraints due to competitive dynamics. Affordable energy uses concentrate model which generates higher margins than finished goods, so will be positive but modest contributor to margin improvement.

Calendar 2025 Q1

You mentioned a bit about supply chain optimization and maybe some purchase timing from bottlers having an impact on the Q1 number

Supply ChainDemandTranscript · FY2025 Q1 →
Show response

Co-CEO explained significant closure days of distribution centers by major bottlers early in Q1, plus FX, weather, and one less selling day. Pointed to robust April as correction.

CHDChurch & Dwight1 question · 1 reporting period · 0 of 1 challenging
CHD company page →

Calendar 2025 Q1

what gives you the confidence that inventory shouldn't bounce back or that there should be a restock

InventoryCompetitive DynamicsPricingTranscript · FY2025 Q1 →
Show response

CEO said order visibility shows no restock coming in Q2 due to flat/negative consumption. On promo: expects levels to rise if categories stay flat, but CHD positioned to gain share.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
PEP PepsiCo922%2 of 9 questions
PG The Procter & Gamble Company90%none of 9 questions
CLX Clorox825%2 of 8 questions
KO The Coca-Cola Company729%2 of 7 questions
STZ Constellation Brands650%3 of 6 questions
CL Colgate-Palmolive50%none of 5 questions
KDP Keurig Dr Pepper50%none of 5 questions
TAP Molson Coors Beverage Company560%3 of 5 questions
CELH Celsius Holdings, Inc.40%none of 4 questions
MNST Monster Beverage30%none of 3 questions
  • PEP
    PepsiCo · 9 questions
    22%2 of 9 questions
  • PG
    The Procter & Gamble Company · 9 questions
    0%none of 9 questions
  • CLX
    Clorox · 8 questions
    25%2 of 8 questions
  • KO
    The Coca-Cola Company · 7 questions
    29%2 of 7 questions
  • STZ
    Constellation Brands · 6 questions
    50%3 of 6 questions
  • CL
    Colgate-Palmolive · 5 questions
    0%none of 5 questions
  • KDP
    Keurig Dr Pepper · 5 questions
    0%none of 5 questions
  • TAP
    Molson Coors Beverage Company · 5 questions
    60%3 of 5 questions
  • CELH
    Celsius Holdings, Inc. · 4 questions
    0%none of 4 questions
  • MNST
    Monster Beverage · 3 questions
    0%none of 3 questions
Show all 11 companies
CompanyQuestionsChallenge rate
CHD Church & Dwight1—Rate withheld: fewer than 3 questions
  • CHD
    Church & Dwight · 1 question
    —rate withheld: under 3 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q340%none of 4 questions3
2024 Q4922%2 of 9 questions9
2025 Q1119%1 of 11 questions11
2025 Q2729%2 of 7 questions7
2025 Q3911%1 of 9 questions9
2025 Q4520%1 of 5 questions5
2026 Q1617%1 of 6 questions5
2026 Q2838%3 of 8 questions8
2026 Q3333%1 of 3 questions2
  1. 2024 Q34 questions · challenge rate 0% (none of 4 questions) · 3 companies
  2. 2024 Q49 questions · challenge rate 22% (2 of 9 questions) · 9 companies
  3. 2025 Q111 questions · challenge rate 9% (1 of 11 questions) · 11 companies
  4. 2025 Q27 questions · challenge rate 29% (2 of 7 questions) · 7 companies
  5. 2025 Q39 questions · challenge rate 11% (1 of 9 questions) · 9 companies
  6. 2025 Q45 questions · challenge rate 20% (1 of 5 questions) · 5 companies
  7. 2026 Q16 questions · challenge rate 17% (1 of 6 questions) · 5 companies
  8. 2026 Q28 questions · challenge rate 38% (3 of 8 questions) · 8 companies
  9. 2026 Q33 questions · challenge rate 33% (1 of 3 questions) · 2 companies

Topics

Topics tagged on this analyst’s questions.

  • Competitive Dynamics26
  • Demand22
  • Capital Allocation11
  • Pricing9
  • Margin8
  • Product Launch7
  • Capex Investment5
  • Innovation & R&D5
  • Macroeconomic5
  • Revenue Growth4
Show all 19 topics
  • Geographic Expansion4
  • M&A4
  • Cost Pressure3
  • Inventory3
  • Guidance Reliability3
  • Fx3
  • Supply Chain2
  • Trade Tariffs2
  • Regulation Policy1